IS THE ORPHANAGE FILLING UP? PROJECTING THE GROWTH AND BUDGET IMPACT OF ORPHAN DRUGS IN EUROPE

被引:4
|
作者
Flostrand, S. [1 ]
Rodriguez, I [2 ]
Maddox, B. [3 ]
Finch, L. [3 ]
Belulaj, S. [3 ]
Gould, A. [4 ]
机构
[1] IMS Consulting Grp, Paris, France
[2] IMS Consulting Grp, Madrid, Spain
[3] IMS Consulting Grp, Cambridge, England
[4] Univ Cambridge, Cambridge, England
关键词
D O I
10.1016/j.jval.2016.09.1454
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSY137
引用
收藏
页码:A599 / A599
页数:1
相关论文
共 28 条
  • [1] Impact of orphan drugs on Latvian budget
    Konstantins Logviss
    Dainis Krievins
    Santa Purvina
    Orphanet Journal of Rare Diseases, 11
  • [2] Impact of orphan drugs on Latvian budget
    Logviss, Konstantins
    Krievins, Dainis
    Purvina, Santa
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [3] Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe
    Schlander, Michael
    Adarkwah, Charles Christian
    Gandjour, Afschin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (01) : 171 - 179
  • [4] Budget-impact of drugs for orphan diseases (orphan drugs) in the Israeli health basket: a longitudinal analysis
    Morginstin, Tal
    Hammerman, Ariel
    Triki, Noa
    Weinreb, Baruch
    ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2019, 8 (01):
  • [5] Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
    Carina Schey
    Tsveta Milanova
    Adam Hutchings
    Orphanet Journal of Rare Diseases, 6
  • [6] REVIEW OF METHODOLOGICAL QUALITY OF BUDGET IMPACT ANALYSES FOR ORPHAN DRUGS
    Abdallah, K.
    Kiani, P.
    Huys, I
    Claes, K.
    Simoens, S.
    VALUE IN HEALTH, 2019, 22 : S771 - S771
  • [7] TREND ANALYSIS OF LISTING AND BUDGET IMPACT FOR ORPHAN DRUGS IN KOREA
    Kim, Y.
    Oh, R.
    VALUE IN HEALTH, 2017, 20 (09) : A567 - A567
  • [8] Estimating the budget impact of orphan medicines in Europe: 2010-2020
    Schey, Carina
    Milanova, Tsveta
    Hutchings, Adam
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [9] Estimating the budget impact of orphan drugs in Sweden and France 2013–2020
    Adam Hutchings
    Carina Schey
    Richard Dutton
    Felix Achana
    Karolina Antonov
    Orphanet Journal of Rare Diseases, 9
  • [10] BUDGET IMPACT OF ORPHAN DRUGS IN THE NETHERLANDS IN THE PERIOD 2006-2012
    Kanters, T. A.
    Steenhoek, A.
    Hakkaart, L.
    VALUE IN HEALTH, 2014, 17 (07) : A525 - A525